Warning Letter — Specialty Health Products CO, LLC
The FDA's Center for Devices and Radiological Health issued a Warning Letter to Specialty Health Products CO, LLC on July 7, 2026, following an inspection or review.
This affects Specialty Health Products CO, LLC, as well as regulatory and quality assurance professionals responsible for medical device compliance under CDRH oversight.
The issuance of a Warning Letter by CDRH indicates that the FDA has identified significant violations of regulatory requirements. This suggests that the firm's quality management system or product clearances may be under scrutiny, potentially leading to restricted product distribution or delayed approvals until corrective actions are verified.
Regulatory and Quality departments should review current manufacturing and quality system protocols to ensure alignment with CDRH expectations. Firms should perform internal audits against 21 CFR 820 requirements to identify potential gaps that could lead to enforcement actions.
FDA Warning Letter issued to: Specialty Health Products CO, LLC. 07/07/2026 — Center for Devices and Radiological Health. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/specialty-health-products-co-llc-726564-07072026
Open in openFDA / FDA.gov